{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T08:44:50Z","timestamp":1788425090493,"version":"build-2803163510"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,9]],"date-time":"2020-01-09T00:00:00Z","timestamp":1578528000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods & Clinical Development"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.omtm.2019.12.014","type":"journal-article","created":{"date-parts":[[2020,1,14]],"date-time":"2020-01-14T00:31:59Z","timestamp":1578961919000},"page":"507-517","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Long-Term Metabolic Correction of Phenylketonuria by AAV-Delivered Phenylalanine Amino Lyase"],"prefix":"10.1016","volume":"19","author":[{"given":"Rui","family":"Tao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoyue","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghai","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biao","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaohua","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2019.12.014_bib1","first-page":"49","article-title":"Phenylketonuria: translating research into novel therapies","volume":"3","author":"Ho","year":"2014","journal-title":"Transl. Pediatr."},{"key":"10.1016\/j.omtm.2019.12.014_bib2","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"1667","article-title":"Hyperphenylalaninemia: phenylalanine hydroxylase deficiency","author":"Scriver","year":"2001"},{"key":"10.1016\/j.omtm.2019.12.014_bib3","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1542\/peds.32.3.338","article-title":"A Simple Phenylalanine Method for Detecting Phenylketonuria in Large Populations of Newborn Infants","volume":"32","author":"Guthrie","year":"1963","journal-title":"Pediatrics"},{"key":"10.1016\/j.omtm.2019.12.014_bib4","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1159\/000363391","article-title":"The micronutrient status of patients with phenylketonuria on dietary treatment: an ongoing challenge","volume":"65","author":"Evans","year":"2014","journal-title":"Ann. Nutr. Metab."},{"key":"10.1016\/j.omtm.2019.12.014_bib5","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/sj.gt.3302262","article-title":"Long-term correction of hyperphenylalaninemia by AAV-mediated gene transfer leads to behavioral recovery in phenylketonuria mice","volume":"11","author":"Mochizuki","year":"2004","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2019.12.014_bib6","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/sj.gt.3302684","article-title":"Administration-route and gender-independent long-term therapeutic correction of phenylketonuria (PKU) in a mouse model by recombinant adeno-associated virus 8 pseudotyped vector-mediated gene transfer","volume":"13","author":"Ding","year":"2006","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2019.12.014_bib7","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1089\/hum.2009.127","article-title":"Comparison of adeno-associated virus pseudotype 1, 2, and 8 vectors administered by intramuscular injection in the treatment of murine phenylketonuria","volume":"21","author":"Rebuffat","year":"2010","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2019.12.014_bib8","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/jgm.1543","article-title":"Complete restoration of phenylalanine oxidation in phenylketonuria mouse by a self-complementary adeno-associated virus vector","volume":"13","author":"Yagi","year":"2011","journal-title":"J.\u00a0Gene Med."},{"key":"10.1016\/j.omtm.2019.12.014_bib9","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/sj.gt.3302678","article-title":"Complete correction of hyperphenylalaninemia following liver-directed, recombinant AAV2\/8 vector-mediated gene therapy in murine phenylketonuria","volume":"13","author":"Harding","year":"2006","journal-title":"Gene Ther."},{"issue":"Suppl 1","key":"10.1016\/j.omtm.2019.12.014_bib10","first-page":"S334","article-title":"Correction of maternal phenylketonuria syndrome in the Pahenu2 missense mutant mouse by r-AAV mediated gene therapy","volume":"9","author":"Laipis","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2019.12.014_bib11","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1753-4887.1971.tb07281.x","article-title":"Mutants: consumers with special needs","volume":"29","author":"Scriver","year":"1971","journal-title":"Nutr. Rev."},{"key":"10.1016\/j.omtm.2019.12.014_bib12","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1016\/S0021-9258(19)61721-7","article-title":"The metabolism of aromatic compounds in higher plants. IV. Purification and properties of the phenylalanine deaminase of Hordeum vulgare","volume":"236","author":"Koukol","year":"1961","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtm.2019.12.014_bib13","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1139\/O07-018","article-title":"A modern view of phenylalanine ammonia lyase","volume":"85","author":"MacDonald","year":"2007","journal-title":"Biochem. Cell Biol."},{"key":"10.1016\/j.omtm.2019.12.014_bib14","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.ymthe.2005.02.013","article-title":"Development of pegylated forms of recombinant Rhodosporidium toruloides phenylalanine ammonia-lyase for the treatment of classical phenylketonuria","volume":"11","author":"G\u00e1mez","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2019.12.014_bib15","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00726-005-0218-5","article-title":"Phenylalanine ammonia-lyase modified with polyethylene glycol: potential therapeutic agent for phenylketonuria","volume":"29","author":"Ikeda","year":"2005","journal-title":"Amino Acids"},{"key":"10.1016\/j.omtm.2019.12.014_bib16","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ymgme.2007.04.015","article-title":"Structure-based epitope and PEGylation sites mapping of phenylalanine ammonia-lyase for enzyme substitution treatment of phenylketonuria","volume":"91","author":"G\u00e1mez","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.omtm.2019.12.014_bib17","doi-asserted-by":"crossref","first-page":"20894","DOI":"10.1073\/pnas.0808421105","article-title":"Preclinical evaluation of multiple species of PEGylated recombinant phenylalanine ammonia lyase for the treatment of phenylketonuria","volume":"105","author":"Sarkissian","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2019.12.014_bib18","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/pr.2017.323","article-title":"Maternal phenylketonuria syndrome: studies in mice suggest a potential approach to a continuing problem","volume":"83","author":"Zeile","year":"2018","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.omtm.2019.12.014_bib19","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ymgme.2011.06.016","article-title":"Evaluation of orally administered PEGylated phenylalanine ammonia lyase in mice for the treatment of Phenylketonuria","volume":"104","author":"Sarkissian","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.omtm.2019.12.014_bib20","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ebiom.2018.10.038","article-title":"Association of immune response with efficacy and safety outcomes in adults with phenylketonuria administered pegvaliase in phase 3 clinical trials","volume":"37","author":"Gupta","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.omtm.2019.12.014_bib21","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1007\/s11095-016-1961-x","article-title":"The Mystery of Antibodies Against Polyethylene Glycol (PEG)\u2014What do we Know?","volume":"33","author":"Lubich","year":"2016","journal-title":"Pharm. Res."},{"key":"10.1016\/j.omtm.2019.12.014_bib22","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/j.drudis.2014.08.015","article-title":"Potential induction of anti-PEG antibodies and complement activation toward PEGylated therapeutics","volume":"19","author":"Verhoef","year":"2014","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.omtm.2019.12.014_bib23","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/mt.2009.246","article-title":"Systematic evaluation of AAV vectors for liver directed gene transfer in murine models","volume":"18","author":"Wang","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2019.12.014_bib24","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s10545-010-9073-y","article-title":"The reality of dietary compliance in the management of phenylketonuria","volume":"33","author":"MacDonald","year":"2010","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"issue":"Suppl","key":"10.1016\/j.omtm.2019.12.014_bib25","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/j.ymgme.2011.08.005","article-title":"Follow up of phenylketonuria patients","volume":"104","author":"Demirkol","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.omtm.2019.12.014_bib26","doi-asserted-by":"crossref","first-page":"G412","DOI":"10.1152\/ajpgi.00590.2007","article-title":"Optimized adeno-associated virus 8 produces hepatocyte-specific Cre-mediated recombination without toxicity or affecting liver regeneration","volume":"295","author":"Ho","year":"2008","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.omtm.2019.12.014_bib27","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1517\/14656566.2015.1013030","article-title":"Alternative therapies to address the unmet medical needs of patients with phenylketonuria","volume":"16","author":"Blau","year":"2015","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.omtm.2019.12.014_bib28","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ymgme.2009.09.002","article-title":"Converting an injectable protein therapeutic into an oral form: phenylalanine ammonia lyase for phenylketonuria","volume":"99","author":"Kang","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.omtm.2019.12.014_bib29","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1182\/blood.V89.4.1254","article-title":"Therapeutic levels of functional human factor X in rats after retroviral-mediated hepatic gene therapy","volume":"89","author":"Le","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2019.12.014_bib30","doi-asserted-by":"crossref","first-page":"6609","DOI":"10.1093\/nar\/gkt404","article-title":"A concept of eliminating nonhomologous recombination for scalable and safe AAV vector generation for human gene therapy","volume":"41","author":"Dong","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtm.2019.12.014_bib31","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.joim.2019.09.004","article-title":"Induction of sub-G0 arrest and apoptosis by seed extract of Moringa peregrina (Forssk.) Fiori in cervical and prostate cancer cell lines","volume":"17","author":"Abou-Hashem","year":"2019","journal-title":"J.\u00a0Integr. Med."}],"updated-by":[{"DOI":"10.1016\/j.omtm.2022.06.008","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T00:00:00Z","timestamp":1662595200000}},{"DOI":"10.1016\/j.omtm.2022.02.009","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T00:00:00Z","timestamp":1646870400000}}],"container-title":["Molecular Therapy - Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S232905012030005X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S232905012030005X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T11:55:22Z","timestamp":1700567722000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S232905012030005X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":31,"alternative-id":["S232905012030005X"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2019.12.014","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.omtm.2022.06.008","asserted-by":"object"},{"id-type":"doi","id":"10.1016\/j.omtm.2022.02.009","asserted-by":"object"}]},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-Term Metabolic Correction of Phenylketonuria by AAV-Delivered Phenylalanine Amino Lyase","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2019.12.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors.","name":"copyright","label":"Copyright"}]}}